TNF and inflammatory bowel disease: However, roughly one-third of patients with IBD are first-line non-responders to TNF-α inhibitor induction therapy [38,39,40,41], and the others become second-line non-responders during TNF-α inhibitor maintenance therapy [42,43,44].